These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2050829)

  • 1. Effect of disopyramide on systolic and early diastolic time intervals in patients with hypertrophic cardiomyopathy.
    Sumimoto T; Hamada M; Ohtani T; Shigematsu Y; Fujiwara Y; Sekiya M; Hiwada K
    J Clin Pharmacol; 1991 May; 31(5):440-3. PubMed ID: 2050829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salutary effect of disopyramide on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy.
    Matsubara H; Nakatani S; Nagata S; Ishikura F; Katagiri Y; Ohe T; Miyatake K
    J Am Coll Cardiol; 1995 Sep; 26(3):768-75. PubMed ID: 7642872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiarrhythmic drug, cibenzoline, can directly improve the left ventricular diastolic function in patients with hypertrophic cardiomyopathy.
    Hamada M; Shigematsu Y; Hara Y; Suzuki M; Ohtsuka T; Hiasa G; Ogimoto A; Saeki H; Suzuki J; Hiwada K
    Jpn Circ J; 2001 Jun; 65(6):531-8. PubMed ID: 11407736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Contribution of hypertension to left ventricular diastolic function in patients with asymmetrical apical hypertrophy].
    Shiotani M; Arita M; Nakamura H; Nakamura Y; Fujiwara S; Yamamoto K; Ueno Y; Nishio I; Masuyama Y
    J Cardiol; 1989 Mar; 19(1):135-45. PubMed ID: 2810033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Left ventricular function at rest and during exercise and the effects of propranolol in patients with hypertrophic cardiomyopathy].
    Amano K; Sakamoto T; Sugimoto T
    J Cardiol Suppl; 1987; 16():35-51. PubMed ID: 3509682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cibenzoline, a class ia antiarrhythmic agent, on left ventricular diastolic function in hypertrophic cardiomyopathy.
    Kondo I; Mizushige K; Nozaki S; Iwado Y; Masugata H; Kohno M; Matsuo H
    Cardiovasc Drugs Ther; 2001 Sep; 15(5):459-65. PubMed ID: 11855665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mode of splitting of the second heart sound in patients with hypertrophic cardiomyopathy].
    Fukuda N; Oki T; Sakai H; Asai M; Ohshima C; Kusaka Y; Tominaga T; Murao A; Niki T; Mori H
    J Cardiogr; 1983 Jun; 13(2):327-41. PubMed ID: 6687124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difference in myocardial characteristics between hypertrophic cardiomyopathy and myocardial hypertrophy due to essential hypertension.
    Hamada M; Matsuzaki K; Kazatani Y; Shigematsu Y; Sekiya M; Ochi T; Ito T; Kokubu T
    Jpn Circ J; 1985 Mar; 49(3):267-75. PubMed ID: 3157012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of calcium-channel blockers and beta-adrenergic blocker on early diastolic time intervals and A-wave ratio in patients with hypertrophic cardiomyopathy.
    Doiuchi J; Hamada M; Ito T; Kokubu T
    Clin Cardiol; 1987 Jan; 10(1):26-30. PubMed ID: 2880684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An equation to predict the changes in peak left ventricular pressure in hypertrophic obstructive cardiomyopathy after treatment: application to the administration of disopyramide.
    Niki K; Sugawara M; Tanino S; Iwade K; Hosoda S; Kasanuki H
    Heart Vessels; 1999; 14(2):72-81. PubMed ID: 10651183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of calcium antagonists or beta-blockade on left ventricular diastolic function in essential hypertension].
    Shiotani M; Arita M; Nakatsu C; Nakamura N; Ohshika H; Nakamura Y; Fujiwara S; Ueno Y; Nishio I; Masuyama Y
    J Cardiol; 1990; 20(1):135-45. PubMed ID: 2093746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disopyramide in hypertrophic cardiomyopathy. I. Hemodynamic assessment after intravenous administration.
    Pollick C; Kimball B; Henderson M; Wigle ED
    Am J Cardiol; 1988 Dec; 62(17):1248-51. PubMed ID: 3195486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Doppler and echocardiographic assessments of effects of disopyramide on non-obstructive hypertrophic cardiomyopathy].
    Nagashima J
    J Cardiol; 1991; 21(1):75-86. PubMed ID: 1817183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of disopyramide on left ventricular diastolic function in hypertrophic cardiomyopathy.
    Fifer MA; O'Gara PT; McGovern BA; Semigran MJ
    Am J Cardiol; 1994 Aug; 74(4):405-8. PubMed ID: 8059710
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of disopyramide on left ventricular diastolic function in patients with hypertrophic cardiomyopathy: comparison with diltiazem.
    Sumimoto T; Hamada M; Ohtani T; Suzuki M; Abe M; Matsuoka H; Fujiwara Y; Sekiya M; Hiwada K
    Cardiovasc Drugs Ther; 1992 Aug; 6(4):425-8. PubMed ID: 1387798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular ejection dynamics in hypertrophic cardiomyopathy and aortic stenosis: comparison with the use of Doppler echocardiography.
    Cogswell TL; Sagar KB; Wann LS
    Am Heart J; 1987 Jan; 113(1):110-6. PubMed ID: 3799425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselective effects of disopyramide enantiomers in humans.
    Lima JJ; Boudoulas H
    J Cardiovasc Pharmacol; 1987 May; 9(5):594-600. PubMed ID: 2439842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Class Ia antiarrhythmic drug cibenzoline: a new approach to the medical treatment of hypertrophic obstructive cardiomyopathy.
    Hamada M; Shigematsu Y; Ikeda S; Hara Y; Okayama H; Kodama K; Ochi T; Hiwada K
    Circulation; 1997 Sep; 96(5):1520-4. PubMed ID: 9315541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of disopyramide on diastolic function in hypertrophic cardiomyopathy.
    Pollick C
    Am J Cardiol; 1995 Mar; 75(8):652. PubMed ID: 7734026
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mode of production of the splitting of the second heart sound in post-extrasystolic beats].
    Fukuda N; Irahara K; Bando S; Minezono K; Yamamoto M; Mikawa T; Ohshima C; Kusaka Y; Asai M; Oki T
    J Cardiogr; 1983 Dec; 13(4):967-79. PubMed ID: 6206169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.